Come and meet DefiniGEN at booth #1745 and hear how our iPSC-derived hepatocyte platform (Opti-HEP) ...
Chris Kirton, CEO and Heidi Kingdon Jones, CBO will be partnering at BIO-Europe in Stockholm, in Nov...
DefiniGEN will be exhibiting at ELRIG at the Excel Centre where we will contribute to CONNECTING MIN...
We will be attending and presenting three posters that demonstrate DefiniGEN’s Opti-HEP superior liv...
French Lewis from DefiniGEN will be attending the Gene Therapy Potency Assay Summit in Boston, July ...
DefiniGEN scientists will be attending the ISSCR in July where we will be presenting 2 posters; one ...
We are thrilled to have our poster entitled “iPSC-derived hepatocytes revisited: improved liver func...
DefiniGEN's Head of R&D, Nikolaos Nikolaou, will be presenting "Optimised iPSC-derived hepatocyt...
DefiniGEN will be attending ELRIG in Gothenburg, 15-16 May 2024.
Come and meet DefiniGEN at booth #1745 and hear how our iPSC-derived hepatocyte platform (Opti-HEP):